Gentian Diagnostics ASA (OSL:GENT)

Gentian Diagnostics ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	722	605	640	632	1,110	840
Market Cap Growth	-5.54%	-5.54%	1.22%	-43.06%	32.20%	-12.61%
Enterprise Value	647	517	574	555	1,000	691
Last Close Price	46.80	39.20	41.50	41.00	72.00	54.50
PE Ratio	16.31	13.35	-	-	-	-
Forward PE	26.22	28.52	-	-	-	-
PS Ratio	4.75	3.98	4.74	5.65	11.10	10.65
PB Ratio	3.72	3.12	4.37	4.10	6.35	4.32
P/TBV Ratio	4.36	3.65	5.10	4.97	7.42	4.32
P/FCF Ratio	59.75	50.05	44.13	-	-	-
P/OCF Ratio	53.63	44.93	41.40	-	-	-
EV/Sales Ratio	4.26	3.40	4.24	4.96	10.00	8.75
EV/EBITDA Ratio	28.87	27.82	-	-	-	-
EV/EBIT Ratio	41.16	32.91	-	-	-	-
EV/FCF Ratio	53.57	42.83	39.55	-	-	-
Debt / Equity Ratio	0.05	0.05	0.09	0.10	0.11	0.11
Debt / EBITDA Ratio	0.45	0.45	-	-	-	-
Debt / FCF Ratio	0.83	0.83	0.90	-	-	-
Asset Turnover	0.74	0.74	0.73	0.56	0.45	0.34
Inventory Turnover	1.67	1.67	1.87	1.54	1.71	1.67
Quick Ratio	3.85	3.85	4.13	4.58	6.10	7.67
Current Ratio	5.38	5.38	5.60	6.33	7.42	8.59
Return on Equity (ROE)	26.59%	26.59%	-7.08%	-14.36%	-13.43%	-8.67%
Return on Assets (ROA)	4.78%	4.78%	-4.32%	-7.27%	-6.39%	-4.82%
Return on Capital (ROIC)	5.40%	5.40%	-4.85%	-8.00%	-6.96%	-5.19%
Return on Capital Employed (ROCE)	7.90%	7.90%	-	-	-	-
Earnings Yield	627.53%	7.49%	-1.66%	-3.74%	-2.23%	-2.08%
FCF Yield	167.37%	2.00%	2.27%	-3.57%	-2.53%	-1.81%
Dividend Yield	85.47%	1.02%	-	-	-	-
Buyback Yield / Dilution	-220.50%	-2.21%	-	-0.04%	-0.07%	-0.01%
Total Shareholder Return	-135.03%	-1.19%	-	-0.04%	-0.07%	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.